JP2010163362A5 - - Google Patents

Download PDF

Info

Publication number
JP2010163362A5
JP2010163362A5 JP2009004247A JP2009004247A JP2010163362A5 JP 2010163362 A5 JP2010163362 A5 JP 2010163362A5 JP 2009004247 A JP2009004247 A JP 2009004247A JP 2009004247 A JP2009004247 A JP 2009004247A JP 2010163362 A5 JP2010163362 A5 JP 2010163362A5
Authority
JP
Japan
Prior art keywords
inhibitor
anthocyanin
rutinoside
cyanidin
delphinidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009004247A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010163362A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2009004247A priority Critical patent/JP2010163362A/ja
Priority claimed from JP2009004247A external-priority patent/JP2010163362A/ja
Publication of JP2010163362A publication Critical patent/JP2010163362A/ja
Publication of JP2010163362A5 publication Critical patent/JP2010163362A5/ja
Pending legal-status Critical Current

Links

JP2009004247A 2009-01-13 2009-01-13 軸性近視抑制剤及び遠視抑制剤 Pending JP2010163362A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009004247A JP2010163362A (ja) 2009-01-13 2009-01-13 軸性近視抑制剤及び遠視抑制剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009004247A JP2010163362A (ja) 2009-01-13 2009-01-13 軸性近視抑制剤及び遠視抑制剤

Publications (2)

Publication Number Publication Date
JP2010163362A JP2010163362A (ja) 2010-07-29
JP2010163362A5 true JP2010163362A5 (enExample) 2012-02-16

Family

ID=42579838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009004247A Pending JP2010163362A (ja) 2009-01-13 2009-01-13 軸性近視抑制剤及び遠視抑制剤

Country Status (1)

Country Link
JP (1) JP2010163362A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018212152A1 (ja) * 2017-05-15 2018-11-22 株式会社坪田ラボ 近視予防用組成物及び機能性食品

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100547497B1 (ko) * 1999-07-02 2006-02-01 메이지 세이까 가부시끼가이샤 식품 조성물, 그의 제조법 및 그것을 함유하는 기능성음식품

Similar Documents

Publication Publication Date Title
CN106536480A8 (zh) 吡咯烷‑2,5‑二酮衍生物、药物组合物及用作ido1抑制剂的方法
EP4342537A3 (en) Semifluorinated alkane compositions
SMT201500213B (it) Alcune triazolopirazine, loro composizioni e metodi d'uso
MX377553B (es) Composicion farmaceutica estable y metodos de uso de la misma.
JP2012106006A5 (enExample)
JP2015525307A5 (enExample)
MX2013005840A (es) Suspenciones herbicidas en capsulas de acetoclor que contienen cantidades reducidas de protector.
CL2014000113A1 (es) Compuestos derivados de quinolinas sustituidas; formulacion farmaceutica que los contiene; y su uso para el tratamiento de una enfermedad que se puede tratar mediante la inhibicion de la enzima syk, tales como rinitis alergica, asma, epoc, bronquitis, lupus eritematoso, esclerosis multiple, osteoporosis, osteopenia y arterioesclerosis.
WO2008025819A3 (en) Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability
CR10665A (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
JP2011519825A5 (enExample)
JP2015500014A5 (enExample)
EP2710892A3 (en) Use of sarmentine and its analogs for controlling plant pests
JP2011528382A5 (enExample)
JP2007320968A5 (enExample)
SMT201300080B (it) Derivati di carbammati di alchiltiazoli, loro preparazione e loro utilizzo come inibitori dell'enzima faah
EP4327880A3 (en) Solid state form of ribociclib succinate
EP3228311A3 (en) Pharmaceutical and nutraceutical compositions of abscisic acid
CN106687453A8 (zh) 作为溴结构域抑制剂的四氢喹啉衍生物
CL2013001643A1 (es) Composicion farmaceutica que comprende: 1)n-[(2s)-2,3-dihidroxipropil]-3-(2-fluoro-4-iodoanilino)piridin-4-carboxamida y 2a)2-amino-n-[3-[[3-(2-cloro-5-metoxianilin)quinoxalin-2-yl]sulfamoil]fenil]-2-metilpropanamida o 2b) 2-amino-8-etil-4-metil-6-(1h-pirazol-5-il)pirido[2,3-d]pirimidin-7-ona ; su uso para el tratamiento del cancer; un kit
JP2011079754A5 (enExample)
CL2008000047A1 (es) Compuestos derivados de sulfonamida; procedimiento de preparacion; composicion farmaceutica que contiene a dichos compuestos; y su uso en el tratamiento y profilaxis de aterotrombosis y asma.
EA201100753A1 (ru) Композиции с пролонгированным высвобождением, содержащие производное 2-оксо-1-пирролидина
JP2010163362A5 (enExample)
JP2008007526A5 (enExample)